Stephanie P Mathews MD

PubMed

• Novel use of Siltuximab in a patient with VEXAS Syndrome.
  Beatriz Cáceres-Nazario, Joshua Rivenbark, Manish K Saha, Stephanie Mathews, Samuel M Rubinstein
  Annals of Hematology. 2025-02-01
• 27 citations
  Early Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.
  David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski
  Blood Advances. 2021-09-13
• 14 citations
  Multi-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.
  Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski
  American Journal of Hematology. 2021-07-29

Abstracts/Posters

• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Stephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Stephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Stephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Stephanie Mathews, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all